The MHRA has announced important new steps which aims to secure access for patients to the latest medical technologies available in Europe and other advanced countries. As well as improving patient access to technologies, the proposals aim to boost medtech industrial growth by reducing duplicative regulatory costs faced by manufacturers and instead focuses the domestic approvals route (UKCA) on first-in-market…
Ben KempJuly 22, 2025